...
首页> 外文期刊>Journal of Clinical Microbiology >Streptococcus pneumoniae DNA Load in Blood as a Marker of Infection in Patients with Community-Acquired Pneumonia
【24h】

Streptococcus pneumoniae DNA Load in Blood as a Marker of Infection in Patients with Community-Acquired Pneumonia

机译:社区获得性肺炎患者血液中的肺炎链球菌DNA负荷是感染的标志

获取原文
           

摘要

Direct detection of Streptococcus pneumoniae DNA in blood adds to culture results in the etiological diagnosis of patients with community-acquired pneumonia (CAP). Quantification of the amount of DNA, the bacterial DNA load (BDL), provides a measurement of DNAemia that may increase the understanding of the clinical relevance of S. pneumoniae DNA in blood. We evaluated the S. pneumoniae BDL as a diagnostic tool in adult patients with CAP. The BDL was determined in whole-blood samples collected simultaneously with blood for culture from 45 adult patients with CAP. After DNA extraction, S. pneumoniae DNA was detected with specific real-time PCR amplification, and the BDL was calculated with a standard curve. PCR and microbiological results were compared, and the BDL was related to clinical and laboratory parameters. S. pneumoniae DNA was detected in 10/13 patients with positive blood cultures and in 67% of patients with microbiologically confirmed pneumococcal pneumonia. The positive predictive values of the receiver operating characteristic curves for the BDLs for pneumococcal infection (100%) and pneumococcal bacteremia (69%) were higher than those for the level of C-reactive protein (CRP; 43% and 23%, respectively) and the white blood cell count (WBC; 42% and 35%, respectively); the negative predictive values of these three parameters were in the same range (±90 and ±97%, respectively). The BDL was higher in patients presenting with systemic inflammatory response syndrome and in patients with bacteremia. Positive correlations were observed for the BDL with WBC, CRP level, and length of stay. We conclude that the BDL supports the diagnosis of S. pneumoniae infection in patients with CAP and provides a putative marker of the severity of disease.
机译:直接检测血液中的肺炎链球菌 DNA可增加培养结果,有助于社区获得性肺炎(CAP)患者的病因诊断。 DNA量(细菌DNA载量(BDL))的定量提供了DNAemia的量度,可增加对 S临床相关性的了解。血液中的肺炎DNA。我们评估了 S。肺炎 BDL作为成人CAP患者的诊断工具。在从45名成年CAP患者中采集的全血样本中同时测定血液中BDL,以进行培养。 DNA提取后, S。实时荧光定量PCR检测肺炎DNA,并用标准曲线计算BDL。比较了PCR和微生物学结果,BDL与临床和实验室参数有关。 S。在10/13血液培养阳性的患者和67%经微生物学确诊的肺炎球菌性肺炎患者中检测到肺炎链球菌DNA。 BDL对肺炎球菌感染(100%)和肺炎球菌菌血症(69%)的接收者工作特征曲线的阳性预测值高于C反应蛋白水平(CRP;分别为43%和23%)和白细胞计数(白细胞;分别为42%和35%);这三个参数的阴性预测值在相同范围内(分别为±90%和±97%)。出现全身性炎症反应综合征的患者和菌血症患者的BDL较高。 BDL与WBC,CRP水平和住院时间呈正相关。我们得出的结论是,BDL支持 S的诊断。 CAP患者的肺炎感染,为疾病的严重程度提供了可能的标志。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号